Literature DB >> 23374570

Regulatory T cells in blood of patients with birdshot retinochoroidopathy.

C Stephen Foster1, Sana S Siddique, Laura Amorese, Lama Mulki, Ana Suelves.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374570     DOI: 10.1016/j.ophtha.2012.09.025

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

Review 1.  Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.

Authors:  Mathilde Leclercq; M Le Besnerais; V Langlois; N Girszyn; Y Benhamou; C Ngo; H Levesque; M Muraine; J Gueudry
Journal:  Clin Rheumatol       Date:  2018-02-03       Impact factor: 2.980

Review 2.  Birdshot retinochoroidopathy.

Authors:  Albert T Vitale
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

Review 3.  Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment.

Authors:  Evangelos Minos; Robert J Barry; Sue Southworth; Annie Folkard; Philip I Murray; Jay S Duker; Pearse A Keane; Alastair K Denniston
Journal:  Orphanet J Rare Dis       Date:  2016-05-12       Impact factor: 4.123

4.  High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis.

Authors:  Fleurieke H Verhagen; Sanne Hiddingh; Rianne Rijken; Aridaman Pandit; Emmerik Leijten; Michel Olde Nordkamp; Ninette H Ten Dam-van Loon; Stefan Nierkens; Saskia M Imhof; Joke H de Boer; Timothy R D J Radstake; Jonas J W Kuiper
Journal:  Front Immunol       Date:  2018-10-31       Impact factor: 7.561

Review 5.  Birdshot Chorioretinopathy: A Review.

Authors:  Elodie Bousquet; Pierre Duraffour; Louis Debillon; Swathi Somisetty; Dominique Monnet; Antoine P Brézin
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.